DDAH1 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with DDAH1 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with DDAH1 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with DDAH1 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with DDAH1 Down.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000125931 - Cbp/p300 interacting transactivator with ED-rich tail 1

Gene

ENSG00000136143 - succinate-CoA ligase ADP-forming subunit beta

Gene

ENSG00000187288 - cell death inducing DFFA like effector c

Gene

ENSG00000165322 - Rho GTPase activating protein 12

Gene

ENSG00000175354 - protein tyrosine phosphatase non-receptor type 2

Gene

ENSG00000167613 - leukocyte associated immunoglobulin like receptor 1

Gene

ENSG00000167759 - kallikrein related peptidase 13

  • Gene

    ENSG00000125931 - Cbp/p300 interacting transactivator with ED-rich tail 1


  • Gene

    ENSG00000136143 - succinate-CoA ligase ADP-forming subunit beta


  • Gene

    ENSG00000187288 - cell death inducing DFFA like effector c


  • Gene

    ENSG00000165322 - Rho GTPase activating protein 12


  • Gene

    ENSG00000175354 - protein tyrosine phosphatase non-receptor type 2


  • Gene

    ENSG00000167613 - leukocyte associated immunoglobulin like receptor 1


  • Gene

    ENSG00000167759 - kallikrein related peptidase 13

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.